Drugs

Papers
(The median citation count of Drugs is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Inhaled Phosphodiesterase Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease379
Xanomeline/Trospium Chloride: First Approval302
Arimoclomol: First Approval269
Treatment Approaches for Carbapenem-Resistant Acinetobacter baumannii Infections247
Advanced-Stage Chronic Myeloid Leukemia: Options for Difficult Treatment Situations217
Iruplinalkib: First Approval208
Empagliflozin: A Review in Symptomatic Chronic Heart Failure193
Mirvetuximab Soravtansine: First Approval164
Safety of Janus Kinase Inhibitors in Inflammatory Bowel Diseases156
Could Sodium/Glucose Co-Transporter-2 Inhibitors Have Antiarrhythmic Potential in Atrial Fibrillation? Literature Review and Future Considerations135
Authors’ Reply to Toda: Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations132
Olutasidenib: First Approval116
Eye Involvement and Management in Inherited Epidermolysis Bullosa111
Spesolimab for the Treatment of Generalized Pustular Psoriasis98
Ensifentrine: First Approval94
Imetelstat: First Approval92
Bone Fragility in Diabetes and its Management: A Narrative Review89
Targeting DNA Damage Response Deficiency in Thoracic Cancers85
Daratumumab: A Review in Newly Diagnosed Systemic Light Chain Amyloidosis85
First-line Immune Checkpoint Inhibitor Combinations in Metastatic Renal Cell Carcinoma: Where Are We Going, Where Have We Been?85
TKI Treatment Sequencing in Advanced Gastrointestinal Stromal Tumors81
Difelikefalin: First Approval78
Tarlatamab: First Approval78
New Topical Therapies in Development for Atopic Dermatitis76
Targeted Therapy Approaches for MET Abnormalities in Non-Small Cell Lung Cancer75
Amisulpride: A Review in Post-Operative Nausea and Vomiting71
Epcoritamab: First Approval71
Authors’ Reply to Bonnet et al. “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”70
New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice70
A Meta-analysis Exploring the Efficacy of Neuropathic Pain Medication for Low Back Pain or Spine-Related Leg Pain: Is Efficacy Dependent on the Presence of Neuropathic Pain?69
Vorasidenib: First Approval69
Correction: Vorasidenib: First Approval68
Mobocertinib: First Approval66
Effectiveness of Interventions to Reduce Opioid Use After Orthopaedic Surgery: A Systematic Review of Randomised Controlled Trials66
Comment on: “The Utilization of the Accelerated Approval Pathway in Oncology: A Case Study of Pembrolizumab”66
Envafolimab: First Approval65
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease63
Innovation in Targeted Intra-articular Therapies for Osteoarthritis63
Vosoritide: First Approval62
Analysis of Cerebrospinal Fluid, Plasma β-Amyloid Biomarkers, and Cognition from a 2-Year Phase 2 Trial Evaluating Oral ALZ-801/Valiltramiprosate in APOE4 Carriers with Early Alzheimer’s Disease Using61
Aprocitentan: First Approval61
Tunlametinib: First Approval60
Sulbactam/Durlobactam: First Approval60
Global Consumption Trend of Antifungal Agents in Humans From 2008 to 2018: Data From 65 Middle- and High-Income Countries60
Casirivimab/Imdevimab: First Approval60
Ocrelizumab: A Review in Multiple Sclerosis60
Glofitamab: First Approval59
Spondyloarthropathy in Inflammatory Bowel Disease: From Pathophysiology to Pharmacological Targets58
Potential Therapeutic Agents That Target ATP Binding Cassette A1 (ABCA1) Gene Expression57
Tamoxifen Dose De-Escalation: An Effective Strategy for Reducing Adverse Effects?57
Tebentafusp: First Approval57
Imeglimin Hydrochloride: First Approval57
Pharmacological Treatment for Pedophilic Disorder and Compulsive Sexual Behavior Disorder: A Review57
Update on the Application of Monoclonal Antibody Therapy in Primary Membranous Nephropathy57
Teclistamab: First Approval57
Contemporary Management of Dyslipidemia57
Trofinetide: First Approval57
New Opportunities to Individualize Frontline Therapy in Advanced Stages of Hepatocellular Carcinoma55
Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update54
Crovalimab: First Approval54
Long-Term Efficacy and Tolerability of PCSK9 Targeted Therapy: A Review of the Literature54
The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin53
Pegcetacoplan: A Review in Paroxysmal Nocturnal Haemoglobinuria53
The Effect of Biological Treatment on Fatigue in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis53
Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences52
Savolitinib: First Approval50
Givosiran: A Review in Acute Hepatic Porphyria50
Avalglucosidase alfa: First Approval50
20-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults47
Etrasimod: First Approval47
Alcohol-Associated Liver Disease: Evolving Concepts and Treatments47
Varenicline Solution Nasal Spray: A Review in Dry Eye Disease46
Gastrointestinal Dysfunction in Parkinson’s Disease46
Pimitespib: First Approval46
Coronary Microvascular Dysfunction in Patients with Non-Obstructive Coronary Arteries: Current Gaps and Future Directions46
Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies46
Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain45
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations44
Bimekizumab for the Treatment of Psoriasis44
Tirzepatide: First Approval43
Tremelimumab: First Approval43
Beremagene Geperpavec: First Approval43
Bexagliflozin: First Approval43
Current Medical Therapy for Adenomyosis: From Bench to Bedside42
Dimdazenil: First Approval42
New Therapies on the Horizon for Primary Biliary Cholangitis41
Sotorasib: First Approval41
Inclisiran: First Approval41
Vamorolone: First Approval41
Correction to: Interchangeability of Biosimilars: Overcoming the Final Hurdles40
Correction to: Valemetostat Tosilate: First Approval40
Correction to: Benefits and Harms of ‘Smart Drugs’ (Nootropics) in Healthy Individuals40
Correction to: Lotilaner Ophthalmic Solution 0.25%: First Approval40
Correction: Iptacopan: First Approval40
Lotilaner Ophthalmic Solution 0.25%: First Approval39
Correction to: Birch Bark Extract: A Review in Epidermolysis Bullosa39
Correction: New Pharmacologic Approaches to the Treatment of Bipolar Depression39
Correction: Lumasiran: A Review in Primary Hyperoxaluria Type 139
Correction: Vonoprazan: A Review in Helicobacter pylori Infection39
Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting39
Exploring Novel Pharmacotherapy Candidates for Cannabis Use Disorder: Uncovering Promising Agents on the Horizon by Mechanism of Action38
Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer’s Disease and Associated Sleep Disorders38
Correction to: Fostamatinib: A Review in Chronic Immune Thrombocytopenia38
Capivasertib: First Approval37
The Effect of Oral Antidiabetic Drugs on Improving the Endocrine and Metabolic States in Women with Polycystic Ovary Syndrome: A Systematic Review and Network Meta-analysis37
How Psychedelics Modulate Multiple Memory Mechanisms in Posttraumatic Stress Disorder37
Iptacopan: First Approval37
Correction to: Secukinumab: A Review in Psoriatic Arthritis36
Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile I36
Motixafortide: First Approval36
Zavegepant: First Approval36
Zastaprazan: First Approval36
Relugolix/Estradiol/Norethisterone Acetate: A Review in Endometriosis-Associated Pain35
Eftrenonacog Alfa: A Review in Haemophilia B34
Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema34
Correction to: Darinaparsin: First Approval34
Correction: Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments34
Personalized Multimorbidity Management for Patients with Type 2 Diabetes Using Reinforcement Learning of Electronic Health Records33
Comment on “Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study”33
Teprotumumab: A Review in Thyroid Eye Disease33
Upacicalcet: First Approval32
Statins and Gliomas: A Systematic Review of the Preclinical Studies and Meta-Analysis of the Clinical Literature32
Nemolizumab: First Approval32
Authors’ Reply to Mazza et al.: “Fluvoxamine for the Early Treatment of SARS‑CoV‑2 Infection: A Review of Current Evidence”32
Chinese Herbal Medicines for Coronary Heart Disease: Clinical Evidence, Pharmacological Mechanisms, and the Interaction with Gut Microbiota32
Comment on: “Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry”31
Authors’ Reply to Colak et al.: “Managing Diabetic Foot Ulcers: Pharmacotherapy for Wound Healing”31
Pharmacotherapy as an Augmentation to Bariatric Surgery for Obesity30
Acknowledgement to Referees30
Dasiglucagon: First Approval30
Eladocagene Exuparvovec: First Approval30
Somatrogon: First Approval30
Repotrectinib: First Approval30
Tafolecimab: First Approval29
Immune Checkpoint Inhibition for Unresectable Malignant Pleural Mesothelioma29
Androgenetic Alopecia: Therapy Update29
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update29
Biologics or Janus Kinase Inhibitors in Rheumatoid Arthritis Patients Who are Insufficient Responders to Conventional Anti-Rheumatic Drugs29
Donafenib: First Approval29
Diagnosis and Treatment of AL Amyloidosis28
Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials28
Authors’ Reply to Denning: Comment on: “Global Consumption Trend of Antifungal Agents in Humans From 2008 to 2018: Data From 65 Middle- and High-Income Countries”28
Sex-Based Outcomes of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis27
Use of Levosimendan in Patients with Pulmonary Hypertension: What is the Current Evidence?26
Maribavir: First Approval26
Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study26
Clinical Outcomes with GLP-1 Receptor Agonists in Patients with Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials25
Finerenone: First Approval25
Targeting KRAS-Mutated Gastrointestinal Malignancies with Small-Molecule Inhibitors: A New Generation of Breakthrough Therapies25
Immune Mechanisms in Epileptogenesis: Update on Diagnosis and Treatment of Autoimmune Epilepsy Syndromes25
Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis24
Efficacy and Safety of CDK4/6 Inhibitors: A Focus on HR+/HER2− Early Breast Cancer24
Botulinum Toxin-A for the Treatment of Myogenous Temporomandibular Disorders: An Umbrella Review of Systematic Reviews24
Drugs in Development to Manage Acute Pain24
A Multicentric, Randomized, Controlled Phase III Study of Centhaquine (Lyfaquin®) as a Resuscitative Agent in Hypovolemic Shock Patients24
Nogapendekin alfa Inbakicept: First Approval23
On the Verge of Precision Medicine in Diabetes23
Treatment Options in Spinal Muscular Atrophy: A Pragmatic Approach for Clinicians23
Nociceptin Receptor-Related Agonists as Safe and Non-addictive Analgesics23
Emerging Therapies for Chronic Hepatitis B and the Potential for a Functional Cure23
Prevention of Rheumatoid Arthritis in At-Risk Individuals: Current Status and Future Prospects23
Surufatinib: First Approval23
Neuropathic Pain and Spinal Cord Injury: Management, Phenotypes, and Biomarkers23
Olipudase Alfa: First Approval23
Mavorixafor: First Approval23
Ivonescimab: First Approval22
Intravenous Methadone for Perioperative and Chronic Cancer Pain: A Review of the Literature22
Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review22
RET Inhibitors in RET Fusion-Positive Lung Cancers: Past, Present, and Future22
Linzagolix: First Approval22
Cefepime/Enmetazobactam: First Approval22
Remdesivir Discontinuation Decisions Based on Thresholds of Aminotransferase in an Observational Registry22
Retifanlimab: First Approval22
Tezepelumab: First Approval21
Evolution of Treatment Paradigms in Newly Diagnosed Multiple Myeloma21
Deucravacitinib: First Approval21
Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry21
Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions21
Melphalan Flufenamide (Melflufen): First Approval21
Lenacapavir: First Approval21
Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine21
Neoadjuvant and Adjuvant Systemic Therapy for Early-Stage Non-small-Cell Lung Cancer21
BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma Therapy21
Acute Pancreatitis: Diagnosis and Treatment21
Atogepant: First Approval20
Results from Expanded Access Programs: A Review of Academic Literature20
Sovateltide: First Approval20
Momelotinib: First Approval20
Danicopan: First Approval20
Targeting the Sphingosine-1-Phosphate Pathway: New Opportunities in Inflammatory Bowel Disease Management19
Postpartum Depression: A Clinical Review of Impact and Current Treatment Solutions19
Renin-Angiotensin-Aldosterone System Modulators in Adults with Hypertension: A Network Meta-Analysis of Randomized Controlled Trials19
Targeting the Angiopoietin/Tie Pathway: Prospects for Treatment of Retinal and Respiratory Disorders19
Dostarlimab: First Approval19
Drug-Induced Pigmentation: A Review19
Interchangeability of Biosimilars: Overcoming the Final Hurdles19
Cabotegravir Extended-Release Injectable Suspension: A Review in HIV-1 Pre-Exposure Prophylaxis19
Drugs in Development to Treat IgA Nephropathy19
Slowing the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes Using Four Pillars of Therapy: The Time to Act is Now19
Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis18
The Potential Role of Clinical Metagenomics in Infectious Diseases: Therapeutic Perspectives18
Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting18
Nintedanib: A Review in Fibrotic Interstitial Lung Diseases18
Concizumab: First Approval18
Ibrexafungerp: First Approval18
Correction to: Pharmacological Approaches to Managing Violence and Aggression in Prison Populations: Clinical and Ethical Issues18
Evinacumab: First Approval18
Drugs in Clinical Development to Treat Autosomal Dominant Polycystic Kidney Disease18
Correction: Estetrol/Drospirenone: A Review in Oral Contraception17
New Pharmacologic Approaches to the Treatment of Bipolar Depression17
Correction to: Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome17
Tegileridine: First Approval17
Rozanolixizumab: First Approval17
Correction to: Lenacapavir: First Approval16
Correction to: Eftrenonacog Alfa: A Review in Haemophilia B16
Reply to the Comments on “Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study”16
Correction: Zilucoplan: First Approval16
Comment on: Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations15
The Future of Microbiome Therapeutics15
Correction to: Entrectinib: A Review in NTRK+ Solid Tumours and ROS1+ NSCLC15
Inavolisib: First Approval15
Avatrombopag: A Review in Thrombocytopenia15
Correction to: Efgartigimod: First Approval15
Correction to: Nadofaragene Firadenovec: First Approval15
Targeting HER2 in Gastroesophageal Cancer: A New Appetite for an Old Plight15
Correction to: Maralixibat: First Approval15
Correction to: Efanesoctocog Alfa: First Approval15
Methadone for Cancer Pain Management in Children: A Review of Literature14
Luspatercept: A Review in Transfusion-Dependent Anaemia due to Myelodysplastic Syndromes or β-Thalassaemia14
Faricimab: First Approval14
Befotertinib: First Approval14
In Search of the Optimal Antithrombotic Regimen for Intracerebral Hemorrhage Survivors with Atrial Fibrillation14
Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?14
Comment on: “Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study”14
Rezvilutamide: First Approval14
Acknowledgement to Referees13
Pharmacological Management of Acute Endodontic Pain13
Reply to Zhang and Zhu “MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19”13
Pyoderma Gangrenosum: Treatment Options13
Aetiology of Significant Liver Test Abnormalities in a Single-Centre Cohort of People with Cystic Fibrosis Exposed to Elexacaftor/Tezacaftor/Ivacaftor, Utilizing the Updated RUCAM13
Comparative Efficacy of Drug Interventions on NAFLD Over 24 Weeks: A Traditional and Network Meta-Analysis of Randomized Controlled Trials13
Mosunetuzumab: First Approval13
Novel Therapy Approaches to Follicular Lymphoma13
Antimicrobial Treatment Options for Difficult-to-Treat Resistant Gram-Negative Bacteria Causing Cystitis, Pyelonephritis, and Prostatitis: A Narrative Review13
Remimazolam: A Review in Procedural Sedation12
Zuranolone: First Approval12
Pharmacologic Management of Persistent Pain in Cancer Survivors12
Combination of PARP Inhibitors and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer12
Tapentadol Versus Tramadol: A Narrative and Comparative Review of Their Pharmacological, Efficacy and Safety Profiles in Adult Patients12
Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going?12
0.15178513526917